Skip to content
777 Sourcing.

Capability

CAR-T cell therapy development

Suppliers
1
States & provinces
1
Countries
1

1 car-t cell therapy development supplier across 1 states and provinces in 1 country. Profiles show capabilities, materials, certifications, and facility locations so you can compare shops and build a shortlist.

Suppliers

Cellula BioPharma is developing a game changing CAR-T platform technology for solid tumors. The company is developing a Nucleotide Metabolic Reprogramed CAR (designated MR CAR), with efficacy and safety validated using in vitro assays and two different tumor mouse models. Their approach targets adenosine (ADO) inhibition, addressing nutrient starvation of T cells in solid tumors.

in vitro assaystumor mouse models

Related capabilities

Other processes offered by the shops that list CAR-T cell therapy development.

Browse all capabilities